High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer

High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer

Aberrant regulation of BCL6 plays crucial oncogenic roles in various malignant tumors; howbeit, the function of BCL6 in tumorigenesis of ovarian cancer remains unclear. The aim of this study is to investigate the role of BCL6 in ovarian cancer. The methods of immunohistochemical staining, quantitati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liancheng Zhu, Huilin Feng, Shan Jin, Mingzi Tan, Song Gao, Huiyu Zhuang, Zhenhua Hu, Huimin Wang, Zuofei Song, Bei Lin
Format:	Article
Language:	English
Published:	SAGE Publishing 2017-06-01
Series:	Tumor Biology
Online Access:	https://doi.org/10.1177/1010428317711655
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis
by: Long Huang, et al.
Published: (2017-06-01)

BCL6 promotes the progression of high-grade serous ovarian cancer cells by inhibiting PLAAT4
by: An Wan, et al.
Published: (2025-07-01)

Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis
by: Jialin Cheng, et al.
Published: (2017-03-01)

Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer
by: Zheng M, et al.
Published: (2025-01-01)

High Co-Expression of <i>GPAT4</i> and <i>SLC7A11</i> as a Predictor of Platinum Resistance and Poor Prognosis in Patients with Epithelial Ovarian Cancer
by: Ping Yu, et al.
Published: (2025-07-01)

High carbohydrate antigen 19–9 levels indicate poor prognosis in patients with bladder cancer following radical cystectomy
by: Sang Won So, et al.
Published: (2025-08-01)

RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer
by: Kyle C. Strickland, et al.
Published: (2025-08-01)

Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells
by: Peruničić-Jovanović Maja, et al.
Published: (2009-01-01)

High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration
by: Songzhe Piao, et al.
Published: (2022-01-01)

High-Risk Genotypes Associated with Poor Response to Controlled Ovarian Stimulation in Indian Women
by: Anuradha Udumudi, et al.
Published: (2023-01-01)

The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
by: Haiqi Su, et al.
Published: (2025-01-01)

Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends
by: Vallathol Dilip Harindran, et al.
Published: (2024-04-01)

Corrigendum: SERPIND1 affects the malignant biological behavior of epithelial ovarian cancer via the PI3K/AKT pathway: a mechanistic study
by: Qian Guo, et al.
Published: (2024-12-01)

TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment
by: Aditi Singh, et al.
Published: (2022-02-01)

Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
by: Qing Yuan, et al.
Published: (2021-12-01)

High-grade, low prostate-specific antigen prostate cancer: Unique hormone-resistant entity with poor survival
by: Vikash Kumar
Published: (2020-01-01)

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.
by: Sharon E Robertson, et al.
Published: (2023-01-01)

Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma
by: Andrea Flesken-Nikitin, et al.
Published: (2024-10-01)

The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
by: Wei Wu, et al.
Published: (2014-01-01)

Low Serum Cholinesterase Levels Predict Poor Prognosis in Patients with Ovarian Cancer
by: Su H, et al.
Published: (2025-02-01)

High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer
by: Bolag Altan, et al.
Published: (2017-07-01)

Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models
by: Zihan Li, et al.
Published: (2025-07-01)

Low expression of CADPS predicts poor prognosis in pediatric acute lymphoblastic leukemia without fusion genes
by: Bin Zhang, et al.
Published: (2025-05-01)

EPITHELIAL OVARIAN CANCER. CLINICAL LECTURE
by: A. E. Solopova, et al.
Published: (2016-10-01)

High expression of SMPD4 promotes liver cancer and is associated with poor prognosis
by: Rongyue Wang, et al.
Published: (2025-04-01)

High PINCH1 Expression in Human Laryngeal Carcinoma Associates with Poor Prognosis
by: Georgios Tsinias, et al.
Published: (2018-01-01)

High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
by: Ryotaro Ohkuma, et al.
Published: (2020-01-01)

Small extracellular vesicle-based one-step high-throughput microfluidic platform for epithelial ovarian cancer diagnosis
by: Yu Wu, et al.
Published: (2025-04-01)

Author Correction: Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma
by: Andrea Flesken-Nikitin, et al.
Published: (2024-11-01)

Dementia with lewy bodies patients with high tau levels display unique proteome profiles
by: Sinead Greally, et al.
Published: (2024-12-01)

High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas
by: Daniela Pretti da Cunha Tirapelli, et al.

Multigene germline and somatic testing for epithelial ovarian cancer in China
by: Lei Li, et al.
Published: (2025-08-01)

The Diagnostic Value of 3.0 T Magnetic Resonance Imaging Combined with Carbohydrate Antigen 125 and Human Epididymis Protein 4 in Epithelial Ovarian Cancer
by: Tie Cao, et al.
Published: (2024-11-01)

High GOLT1A expression induces poor prognosis in papillary thyroid carcinoma
by: Tianjiao Ding, et al.
Published: (2025-07-01)

High expression of HECW1 is associated with the poor prognosis and cancer progression of gastric cancer
by: Zhihui Yang, et al.
Published: (2025-05-01)

Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with poor ovarian response: protocol for a multicentre, randomised, controlled trial
by: Fang Wang, et al.
Published: (2023-12-01)

Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
by: Lina Lin, et al.
Published: (2021-12-01)

NuMA overexpression in epithelial ovarian cancer.
by: Anke Brüning-Richardson, et al.
Published: (2012-01-01)

Optimal cytoreduction for advanced epithelial ovarian cancer
by: N. G. Kormosh, et al.
Published: (2014-08-01)

The effects of obesity on surgical complications and postoperative prognosis of epithelial ovarian cancer: a meta-analysis
by: Jingjing Sheng, et al.
Published: (2025-03-01)